"Choosing Surface Disinfectants," by Kathryn Dix, page 14.

1. National Institutes of Health, Division of Safety. Biologicaldecontamination: methods of disinfection.

2. Crawford L, Yu Z, Keegan L, Yu T. A comparison of commonly used surfacedisinfectants. Infection Control Today. November 2000, 1-9.

3. OSHA. Frequently Asked Questions: Bloodborne Pathogens.

4. Centers for Disease Control and Prevention. Sterilization or disinfectionof patient-care equipment: HIV related.

5. Rutala WA. APIC guideline for selection and use of disinfectants. Am JInfect Control. 1996;24:313-342.

6. Rutala WA, Weber DJ. New disinfection and sterilization methods. EmergingInfect Diseases. 2001; 7(2): 348-53.

7. 08/06/02.

Battling Biofilm: Surface Science, Antimicrobials Help Combat MedicalDevice-Related Infections," by Kelly M. Pyrek, page 32.

1. Katz J. Coating and surface treatment technology.

2. Lin TL, et al. Antimicrobial coatings: a remedy for medical device-relatedinfections.

3. Donlan RM. Biofilms and device-related infections.

4. Ibid.

5. Katz J. Coating and surface treatment technology.

6. Lin TL, et al. Antimicrobial coatings: a remedy for medical device-relatedinfections.  

7. Maki DG. Infections due to infusion therapy. In: Bennett JV, Brachman PS,eds. Hospital Infections. 3rd ed. Boston: Little, Brown; 1992.

8. Plott R, Polk B, Murdock B, et al. Mortality associated with nosocomialurinary tract infection. New Engl J Med. 30(11):637-642, 1982.

9. Watson SK, Lichtenberg DA, Wainwright H. Technology vs. the most commonnosocomial infection. Infection Control Today.

10. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venouscatheter-related bloodstream infection by use of an antiseptic-impregnatedcatheter. Ann Intern Med. 1997;127:267-74.

11. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, et al.Central venous catheters coated with minocycline and rifampin for the preventionof catheter-related colonization and bloodstream infections. Ann Intern Med.1997;127:267-74.


13. Davis RL and Etris SF. The development and functions of silver in waterpurification and disease control. The Silver Institute, Washington, D.C.

14. Silver-coated catheters cut infection.

15. Katz J. Coating and surface treatment technology.

16. Rosenblatt AA and Knapp JE. Chlorine dioxide gas sterilization. HIMAConference Proceedings, pp 47-50.

"Fighting the Flu," by Susan Dolan, RN, MS, CIC, page 46

1. American Academy of Pediatrics. 2000 red book: report of the Committee onInfectious Diseases. 25th ed. Elk Grove Village, IL: American Academy ofPediatrics, 2000:351-9.

2. Bolyard EA, Tablan OC, Williams WW, et al., for the Hospital InfectionControl Practices Advisory Committee. Guideline for infection control in healthcare personnel. Am J Infect Control. 1998;26:289-354.

3. CDC. Prevention and control of influenza. Recommendations of the AdvisoryCommittee On Immunization Practices (ACIP). MMWR 2002; 51(RR03):1-31.

4. CDC. Delayed influenza vaccine availability for the 2001-02 season andsupplemental recommendations of the Advisory Committee on Immunization Practices[Notice to readers]. MMWR 2001;50:582-5.

5. Garner JS, for the Hospital Infection Control Practices AdvisoryCommittee. Guideline for isolation precautions in hospitals. Infect Control HospEpidemiol. 1996;17:53-80.

6. Hendrick JA, Barzilai A, Behre U, et al. Zanamivir for treatment ofsymptomatic influenza A and B infection in children five to twelve years of age:a randomized controlled trial. Pediatr Infect Dis J. 2000;19:410-17.

7. MIST (Management of Influenza in the Southern Hemisphere Trialists) StudyGroup. Randomised trial of efficacy and safety of inhaled zanamivir in treatmentof influenza A and B virus infections. Lancet. 1998;352:1877-81.

8. Monto AS, Fleming DM, Henry D, et al. Efficacy and safety of theneuraminidase inhibitor zanamivir in the treatment of influenza A and B virusinfections. J Infect Dis. 1999;180:254-61.

9. Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated andcold-adapted vaccines against influenza A infection, 1985--1990: the pediatricexperience. Pediatr Infect Disease J. 2001;20:733-40.

10. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment ofinfluenza in children. Pediatr Infect Dis J. 2001;20:127-33.

11. Internet resources:

Related Videos
Set of white bottles with cleaning liquids on the white background. (Adobe Stock 6338071172112 by zolnierek)
Association for the Health Care Environment (Logo used with permission)
Woman lying in hospital bed (Adobe Stock, unknown)
Photo of a model operating room. (Photo courtesy of Indigo-Clean and Kenall Manufacturing)
Mona Shah, MPH, CIC, FAPIC, Construction infection preventionist  (Photo courtesy of Mona Shah)
UV-C Robots by OhmniLabs.  (Photo from OhmniLabs website.)
CDC  (Adobe Stock, unknown)
(Adobe Stock 90930195 by enrico113)
Laparoscopy(Adobe Stock 338216574 by Damian)
Sterile processing   (Adobe Stock, unknown)
Related Content